BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Maryland Department of Business & Economic Development To Reorganize In Hopes Of Growing State's Biotechnology Industry


9/9/2008 7:32:27 AM

Washington Business Journal -- The Maryland Department of Business and Economic Development said Monday it is reorganizing in hopes of growing the state’s biotechnology industry and boosting its international profile.

The changes were unveiled by DBED Secretary David Edgerley. The operational structure “better aligns DBED staff and resources with its core missions: Growing Maryland’s biotechnology industry; expanding the state’s global presence; improving service to Maryland businesses; supporting tourism, film and the arts; and create new jobs and economic opportunities for Marylanders,” Edgerley wrote.

The new framework will enable DBED to operate more efficiently and improve its service delivery during a time of great economic uncertainty on many levels. No jobs at the agency will be cut, Edgerley said in an interview Monday, but none will be added, either. The department also won’t be seeking an increase to its roughly $130 million budget — a tough sell at a time when lawmakers grapple with budgetary shortfalls brought on by slumping revenue from taxes and fees.

“The work is the same game but the playbook will be new,” Edergley said. “We plan to do the same job with the same people for less [money].”

DBED was organized into seven divisions, which have been consolidated to three — economic development, marketing and business development, and tourism, film and the arts.

The Maryland Biotechnology Center, a cornerstone of Gov. Martin O’Malley’s push to invest $1.1 billion in the state’s bioscience industry over the next 10 years, will fall under DBED’s purview. Envisioned by O’Malley as a “one-stop shop to showcase and support biotechnology innovation and entrepreneurship,” it will coordinate a variety of state, higher education and private sector initiatives to fund and grow companies and train a life sciences work force.

The state’s new Office of International Trade and Investment, meanwhile, will boost marketing efforts across the globe in hopes of attracting more foreign investment. An advisory council of private-sector executives will counsel the department on doing business internationally.




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->